Skip to main content

Advertisement

Table 3 Study population

From: Clinical evaluation of left ventricular function and morphology using an accelerated k-t sensitivity encoding method in cardiovascular magnetic resonance

  Patients (n = 26) Volunteers (n = 16) p value
Demographics
 Age, years 53 ± 13 43 ± 14 < 0.001
 Male, n (%) 17 (65) 10 (63) 0.91
 BMI, kg/m2 29 ± 6 26 ± 3 0.004
 BSA, m2 1.91 ± 0.27 1.83 ± 0.24 0.33
 HR, bpm 68 ± 17 63 ± 17 0.73
 PVC, n (%) 1 (4%)
Cardiovascular risk factors
 Hypertension, n (%) 17 (65) 1 (6)
 Diabetes, n (%) 8 (31)
 Hypercholesterolemia, n (%) 11 (42)
 Smoking, n (%) 10 (39)
Diagnosis
 HCM, n (%) 7 (27)
 Ischemic heart disease, n (%) 6 (24)
 Chagas heart disease, n (%) 3 (11)
 DCM, n (%) 3 (11)
 Other cardiomyopathies, n (%) 7 (27)
CMR findingsa
 LVEDVI, mL/m2 92 ± 50 66 ± 10 0.01
 LVESVI, mL/m2 52 ± 53 26 ± 10 0.04
 LVMI, g/m2 80 ± 28 54 ± 10 < 0.001
 LVSV, mL 76 ± 25 75 ± 15 0.90
 LVEF, % 52 ± 21 62 ± 5 0.05
  1. BMI body index mass, BSA body surface area, HR heart rate, PVC premature ventricular contraction, HCM hypertrophic cardiomyopathy, DCM dilated cardiomyopathy, CMR cardiovascular magnetic resonance, LVEDVI left ventricle end-diastolic volume index, LVESVI left ventricle end-systolic volume index, LVMI left ventricle mass index, LVSV left ventricle stroke volume, LVEF left ventricle ejection fraction
  2. Plus-minus values are means ± SD
  3. aLV measurements obtained from 2D-SSFP cine